Hepatocellular carcinoma recurrence after directly-acting antiviral therapy: caution with hepatitis C

被引：0
|
作者：
Ng, Alexander [1 ]
机构：
[1] UCL, Fac Laws, Gower St, London WC1E 6BT, England
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 33卷
关键词：
D O I：
10.1097/MEG.0000000000002193
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1091 / E1092
页数：2
相关论文
共 50 条
  • [21] Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
    Guarino, Maria
    Vigano, Luca
    Ponziani, Francesca Romana
    Giannini, Edoardo Giovanni
    Lai, Quirino
    Morisco, Filomena
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (11) : 1105 - 1114
  • [22] Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy
    Venkata Rajesh Konjeti
    Binu V. John
    Current Treatment Options in Gastroenterology, 2018, 16 (2) : 203 - 214
  • [23] Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
    Lin, Wei-Chen
    Lin, Yang-Sheng
    Chang, Chen-Wang
    Chang, Ching-Wei
    Wang, Tsang-En
    Wang, Horng-Yuan
    Chen, Ming-Jen
    PLOS ONE, 2020, 15 (05):
  • [24] Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
    Tse, Chung Sang
    Yang, Ju Dong
    Mousa, Omar Y.
    Nelson, Kevin M.
    Pungpapong, Surakit
    Keaveny, Andrew
    Aqel, Bashar A.
    Vargas, Hugo
    Dickson, Rolland C.
    Watt, Kymberly
    Gores, Gregory J.
    Roberts, Lewis R.
    Leise, Michael D.
    TRANSPLANTATION DIRECT, 2021, 7 (01): : E635
  • [25] Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
    Calca, Rita
    Jorge, Cristina
    Lebre, Luis
    Cacheira, Eunice
    Querido, Sara
    Nascimento, Celia
    Adragao, Teresa
    Bruges, Margarida
    Weigert, Andre
    Machado, Domingos
    NEFROLOGIA, 2020, 40 (06): : 675 - 676
  • [26] Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?
    Maan, Raoel
    Feld, Jordan J.
    GASTROENTEROLOGY, 2017, 153 (04) : 890 - 892
  • [27] Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection
    Watanabe, Takao
    Tokumoto, Yoshio
    Joko, Kouji
    Michitaka, Kojiro
    Horiike, Norio
    Tanaka, Yoshinori
    Tada, Fujimasa
    Kisaka, Yoshiyasu
    Nakanishi, Seiji
    Yamauchi, Kazuhiko
    Yukimoto, Atsushi
    Hirooka, Masashi
    Abe, Masanori
    Hiasa, Yoichi
    HEPATOLOGY RESEARCH, 2019, 49 (02) : 136 - 146
  • [28] Risk of hepatocellular carcinoma recurrence in patients treated with direct acting antiviral therapy
    Kilsny, Shimaa
    Gomaa, Asmaa
    Sabry, Aliaa
    Moaz, Inas
    Ezzat, Sameera
    Elwaraky, Mohamed
    Badra, Gamal
    Waked, Imam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S606 - S606
  • [29] Antiviral Therapy for Hepatitis C Reduces Early Recurrence of Hepatocellular Carcinoma Following Liver Transplantation
    Kohli, Vivek
    Singhal, Ashish
    Li, Shi-Feng
    Eliott, Lenzi
    Gates, Clay
    Jalil, Sajid
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 84 - 84
  • [30] Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation
    Kohli, Vivek
    Singhal, Ashish
    Elliott, Lenzi
    Jalil, Sajid
    TRANSPLANT INTERNATIONAL, 2012, 25 (02) : 192 - 200
12345